Fish as Brain Food

Eating fish is associated with an increase in brain volume, but it is apparently not because of its omega-3 content, a new study has found.

Researchers analyzed data from 260 cognitively normal people, average age 78, who had answered diet questionnaires. They’d also had their blood levels of omega-3 fatty acids measured and their brains scanned.

The researchers found that weekly consumption of baked or broiled fish — but not fried fish — was associated with larger gray matter volumes in areas of the brain responsible for memory and cognition, including areas where amyloid plaques, a sign of Alzheimer’s disease, first appear. The association persisted after controlling for age, sex, race, education, physical activity, body mass index and any tissue damage found on the initial magnetic resonance imaging scan of the brain.

Grilled Fish Entree in Barcelona

The results were the same regardless of omega-3 levels, suggesting that omega-3s were not the determining factor. The study appears in The American Journal of Preventive Medicine.

The lead author, Dr. Cyrus A. Raji, a radiology resident at the Ronald Reagan U.C.L.A. Medical Center, said that eating fish once a week — there was no additional benefit in eating more — and living a generally healthy lifestyle were enough.

“Physical activity, weight control, and so on — these factors influence the brain more than any supplement or any medicine. It’s much more in our control than we thought.”

Source: newyork times


FDA Approves New DVT Treatment

The FDA has approved the use of the anti-clotting drug apixaban (Eliquis) to treat deep vein thrombosis (DVT) and pulmonary embolism (PE).

Apixaban is also now approved to lower the risk of DVT and PE returning in people who’ve already had one.

The FDA posted a copy of an Aug. 19 letter to drugmaker Bristol-Myers, announcing its decision. Apixaban was already approved for use in lowering the risks of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem and to prevent DVT and PE in people who’ve had hip- or knee-replacement surgery.

FDA Approves New DVT Treatment

Last month the European Commission granted a similar extension of apixaban in countries where drug policies are covered by the European Medicines Agency.

Other blood thinners, including rivaroxaban (Xarelto)and dabigatran (Pradaxa), are also FDA-approved for the treatment of DVT and PE and the prevention of DVT or PE’s return.

Source: web md


E-Cigarettes Should be a Last Resort, Heart Doctors Say

E-cigarettes should be outlawed for minors and only be used as a last resort to quit smoking, the American Heart Association says in a new policy statement. And the Food and Drug Administration should hurry up and regulate them, the group says. “Over the last 50 years, 20 million Americans died because of tobacco. We are fiercely committed to preventing the tobacco industry from addicting another generation of smokers,” Nancy Brown, CEO of the American Heart Association, says in a statement. “Recent studies raise concerns that e-cigarettes may be a gateway to traditional tobacco products for the nation’s youth, and could renormalize smoking in our society.”

E-Cigarettes Should be a Last Resort, Heart Doctors Say

The Food and Drug Administration says it plans to regulate e-cigarettes, along with cigars and other tobacco products. Many “vapers” who use e-cigarettes say regulation will damage a product that’s a far safer substitute for cigarettes. The Heart Association disagrees. “In the years since the FDA first announced it would assert its authority over e-cigarettes, the market for these products has grown dramatically,” Brown said. “We fear that any additional delay of these new regulations will have real, continuing public health consequences.”

Source: nbc news


Double vaccines ‘could hasten the end of polio’

Using both types of polio vaccine could speed up efforts to free the world of the disease, research suggests.

The oral vaccine is leading the fight to eradicate polio, but trials in India show an additional injection of inactivated virus boosts immunity.

The World Health Organization said the findings, published in the journal Science, were “truly historic”.

The disease, which is spread through contaminated faeces, can cause paralysis and even death.

Double vaccines 'could hasten the end of polio'

Fighting polio has been one of the biggest success stories in global health.

In 1988, there were 350,000 cases of polio in more than 125 countries.

The disease is now widespread in just three countries – Nigeria, Afghanistan and Pakistan – and cases have fallen by more than 99%.

Vaccines
Two drops of the oral vaccine, which contains a weakened polio virus, is the preferred tool in eradication efforts because it is cheap and gives resistance in the digestive tract to lower transmission of the virus.

The injected vaccine works largely in the bloodstream.

“But the oral vaccine is less effective in exactly those places we’d like it to work,” one of the researchers, Prof Nicholas Grassly, of Imperial College London, told the BBC.

It is thought other infections may interfere with the vaccine.

The solution has been multiple vaccination. As part of India’s successful eradication campaign, some children received 30 doses by the age of five.

Source: bbc news


British scientists create first complete working organ from cells

British scientists have built a complete and functional organ in a living animal for the first time

British scientists have produced the first working organ by reprogramming cells in a step towards the ‘Holy Grail’ of being able to grow replacement organs for humans.

In future the technique, so far only tested on mice, could be used to provide replacement organs for people with weakened immune systems and eventually lead on the production of more complex organs for transplant. The technique could be used in humans in ten years.
Scientiststs created a working thymus, a vital immune system “nerve centre” located near the heart, with connective tissue cells from a mouse embryo which were converted into a completely different cell strain by flipping a genetic “switch” in their DNA.

The resulting cells grew spontaneously into the whole organ when injected into the mouse with other similar cells.

British scientists have built a complete and functional organ in a living animal for the first time

Professor Clare Blackburn, from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh, who led the team of scientists, said: “The ability to grow replacement organs from cells in the lab is one of the ‘holy grails’ in regenerative medicine. But the size and complexity of lab-grown organs has so far been limited.

“By directly reprogramming cells we’ve managed to produce an artificial cell type that, when transplanted, can form a fully organised and functional organ. This is an important first step towards the goal of generating a clinically useful artificial thymus in the lab.”

The thymus is the central hub of the immune system sending out infection fighting T-cells.

People with a defective thymus lack functioning T-cells and are highly vulnerable to infections. This is especially hazardous for bone marrow transplant patients, who need a working thymus to rebuild their immune systems after surgery.

Around one in 4,000 babies born each year in the UK have a malfunctioning or completely absent thymus, due to rare conditions such as DiGeorge syndrome.

Thymus disorders can be treated with infusions of extra immune cells or transplantation of a new organ soon after birth. However, such approaches are severely limited by a lack of donors and tissue rejection.

The new research, published in the journal Nature Cell Biology, raises the possibility of creating a whole new functioning thymus using cells manufactured in the laboratory.
While fragments of organs, including hearts, livers and even brains, have been grown from stem cells, no one before has succeeded in producing a fully intact organ from cells created outside the body.

Dr Rob Buckle, head of regenerative medicine at the MRC, said: “Growing ‘replacement parts’ for damaged tissue could remove the need to transplant whole organs from one person to another, which has many drawbacks – not least a critical lack of donors.

“This research is an exciting early step towards that goal, and a convincing demonstration of the potential power of direct reprogramming technology, by which once cell type is converted to another. However, much more work will be needed before this process can be reproduced in the lab environment, and in a safe and tightly controlled way suitable for use in humans.”

Chris Mason, Professor of Regenerative Medicine at University College London, said: “Using living cells as therapies has the big advantage in that the functionality of cells is many orders of magnitude greater than that of conventional drugs. Nowhere is this level of functionality more needed than in curing disorders of the immune system.

“The time and resources required to turn this mouse proof-of-concept study into a safe and effective routine therapy for patients will be very significant – 10 years and tens of millions of pounds at a bare minimum. Even the starting point, the underpinning science, is far from complete: for example, not all the cells that are required can yet be made in the lab. However, the … data strongly support the urgent need for more scientists, together with engineers and clinicians, to now get involved in order to evaluate and develop this new technology.”

Dr Paolo de Coppi, consultant paediatric surgeon at Great Ormond Street Hospital and head of Stem Cells and Regenerative Medicine at the Institute of Child Health, London, said: “Research such as this demonstrates that organ engineering could, in the future, be a substitute for transplantation, overcoming problems such as organ donor shortages and bypassing the need for immunosuppressive therapy.

“It remains to be seen whether, in the long term, cells generated using direct reprogramming will be able to maintain their specialised form and avoid problems such as tumour formation.”

Source: The telegraph


Nigeria: Bodies of Ebola Victims Cremated in Lagos

Bodies of the four Nigerians, who died of Ebola Virus Disease, EVD, have been cremated in line with World Health Organisation, WHO, requirements for disposal of such corpses. The body of the index (first) case, Patrick Sawyer was the first to be cremated on July 25, 2014.

The decision to cremate the bodies, it was gathered, may not be unconnected with the deadly nature of the Ebola Virus which is known to be easily transmissible from human to human during handling of corpses of victims.

A health official at the Emergency Operation Centre, EOC, of the Mainland Hospital, Lagos, who confirmed the development, said the Lagos State Government in following strict guidelines for disposal of the bodies, authorised cremation of all the bodies.

Bodies of Ebola Victims Cremated in Lagos

The official who pleaded anonymity said the decision to cremate all bodies was to ensure appropriate containment measures and guarantee proper handling of the bodies.

“All the bodies of those who died of Ebola from this centre have been cremated. None was allowed to undergo traditional burial because extreme care is being taken to prevent further infections,” the official noted.

The WHO in recommending that people who die from Ebola should be promptly and safely buried, notes that cremation, which is the application of high temperature to reduce bodies to basic chemical components (ashes), is ideal for safe disposal of bodies of such persons in order to minimise further transmission.

In a statement weekend, the ECOWAS Commission stated that the remains of its Protocol Assistant at the Lagos Liaison Office, Mr. Salihu Abdulqudir Jatto, who succumbed to the Ebola Virus Disease, EVD, on August 12, 2014, had been laid to rest in a private ceremony in Ikorodu, Lagos state.

The statement said a delegation from the Commission had earlier paid a condolence visit to the deceased’s widow and other members of his family.

Jatto was among persons that assisted the American-Liberian Mr. Patrick Sawyer, and contracted the disease from the late Sawyer who took ill on arrival in Nigeria on July 20, 2014 on his way to a regional conference in Calabar, and later died in a Lagos hospital of the EVD.

The statement noted that prior to the burial last Friday, a special prayer service in honour of the deceased was held at the Commission’s Abuja Headquarters. The activity was presided over by Vice President of the Commission Dr. Toga Gayewea McIntosh who represented the President of the Commission, Kadré Desire Ouédraogo.

Glowing tributes were paid in memory of Jatto, who was variously described as a diligent, passionate, humble and hardworking staff, who died a hero in the course of duty.

Leading the other mourning colleagues in the outpouring of grief, McIntosh described Jatto as “a sharp, young, aggressive goal-getter and a personal friend.

“We are all touched by his death, which is both a personal and collectively loss,” McIntosh said, praying for the repose of Jatto’s soul.

Head of Protocol at the Commission, Mr. Steve Onwuka, narrated examples of Jatto’s unique “unassuming, humble and infectious” character and recalled that Jatto died at a time the world attention was focused on the region, albeit for the Ebola health emergency.

Others who spoke at the occasion, include Mr. Hyacinth Okwu, of the Finance Directorate; Mr. Franck Afanyiakossou, and Mr. Joshua Iyamu, a member of the Staff Association, all acknowledged Jatto’s legacy of service and exemplary character.

They appealed for improvement of the staff welfare and asked for special care of Jatto’s wife and children given the circumstance of his death.

Earlier, Mr. Saihou Njie, of the Human Resources Directorate said the ceremony was part of the traditional gestures of honour to a departed colleague.

Source: all africa


Aspirin not only prevents pain but also promotes recovery

According to a new study published online in PNAS, aspirin has a dual role in acting on pain. Not only does it prevent inflammation and pain but also hastens the end of inflammation.

According to the study, the drug kills cyclooxygenase, thus preventing production of the prostaglandins that cause inflammation and pain and also prompts the enzyme to generate another compound that hastens the end of inflammation, returning the affected cells to homeostatic health.  Edward A. Dennis said that aspirin causes the cyclooxygenase to make a small amount of a related product called 15-HETE and during infection and inflammation, the 15-HETE can be converted by a second enzyme into lipoxin, which is known to help reverse inflammation and cause its resolution – a good thing.

Aspirin not only prevents pain but also promotes recovery

The researchers found that macrophages contain the biochemical tools to not just initiate inflammation, a natural part of the immune response, but also to promote recovery from inflammation by releasing 15-HETE and converting it into lipoxin as the inflammation progresses.

Here are some other amazing facts about aspirin you should know:

1. It is the most widely used drug: Aspirin, chemically known as acetylsalicylic acid, is truly a boon to the medical world. This wonder drug was first brought to the pharmaceutical industry in the year 1899, when it was introduced for the treatment of rheumatic fever and gout. Since then it is the most extensively used therapeutic chemical and is still the first choice of treatment for minor pains and fever.

2. Most people take the drug without even realising it:  Most people don’t realise that they are actually taking an aspirin because it is not only found as a single ingredient but is also present in combination with other prescribed and over-the-counter drugs. Most drugs containing aspirin have it labelled as ASA or spelled out as acetylsalicylic acid.

3. It is used for relieving more than 50 symptoms: The role of aspirin in treatment of various conditions has been studied. Aspirin is most commonly used for symptoms like heartburn, fever, arthritis, stomach ache, sleep disorders, migraine headaches and symptoms of common cold.

4. Aspirin could benefit 11 different cancers: Aspirin has a significant ability to inhibit the growth of cancer cells. A new aspirin drug showed to curb the growth of cancer cells including that of colon, pancreatic, lung, prostate, breast and leukemia.

Source: The health site


Two U.S. Ebola Patients Released From Hospital

Two American missionaries who contracted Ebola in Liberia have recovered from the deadly illness and been discharged, Emory University Hospital officials said Thursday.

Smiling broadly as he appeared at a hospital news conference and looking as fit as he had in photos taken before he became ill, Kent Brantly said he was grateful to have survived a disease that kills the majority of those infected.

Two U.S. Ebola Patients Released From Hospital

“I am thrilled to be alive, to be well, and to be reunited with my family,” said Dr. Brantly, a 33- year-old medical missionary from Fort Worth, Tex.

Dr. Brantly and Nancy Writebol, 59 years old, spent more than two weeks in a special isolation unit at the hospital after a medical evacuation from Liberia by the two Christian charities for whom they worked. Mrs. Writebol was discharged and quietly left the hospital Tuesday, officials said Thursday.

The patients, who contracted the disease while working at the same hospital in Liberia, no longer have symptoms and don’t have traces of the deadly virus in their blood, said Bruce Ribner, who heads the isolation unit where they were treated.

“There is no evidence of Ebola virus infection in their bodies,” he said. They pose “no public health threat.” Recovered Ebola patients generally “are not contagious, they don’t as a general rule relapse, and they don’t spread the virus to anyone else.”

Moreover, they are immune to the strain of Ebola virus that infected them, Dr. Ribner said—a strain that caused an outbreak that has infected at least 2,473 people in Guinea, Liberia, Sierra Leone and Nigeria, killing 1,350 of them.

The two were discharged by Emory after consultation with the Centers for Disease Control and Prevention and state health officials in Georgia and North Carolina, Dr. Ribner said.

The bearded Dr. Brantly, wearing khaki pants and a blue shirt with the logo of Samaritan’s Purse, the charity he works for, appeared healthy as he addressed journalists, with his wife Amber by his side. He choked up at times while thanking his medical team and the charity. He then hugged the roughly 30 people from his treatment team, including doctors, nurses and support staff, conveying that he was no longer infectious. Many recovered Ebola patients in West Africa are shunned. “God saved my life, the direct answer to thousands and thousands of prayers,” he said.

Dr. Brantly said he would be going away with his family for a while to recover. Mrs. Writebol already is with her husband at an undisclosed location, said SIM USA, the Christian charity where she worked.

In a statement issued Thursday, her husband, David Writebol said,”The lingering effects of the battle have left her in a significantly weakened condition. Thus, we decided it would be best to leave the hospital privately to be able to give her the rest and recuperation she needs at this time.”

While in treatment in Liberia, the two Americans received an experimental drug, called ZMapp, which is made by San Diego-based Mapp Biopharmaceutical Inc. and had never been tested in humans. On Thursday, Dr. Ribner said it’s impossible to know what the effect of the drug was on the two.

“Frankly we do not know whether it helped them, whether it made no difference, or even theoretically if it delayed their recovery,” Dr. Ribner said.

“There is a crying need for research on these agents,” he said.Three doctors in Liberia have been given the same drug, and all are responding, said Director of Social Welfare John Sumo at the Ministry of Health. He didn’t know if or how those doctors were being monitored for research purposes.

On its website, Mapp says that the combination of antibodies that make up ZMapp were identified only last January, and that “larger trials are necessary to determine whether ZMapp is safe and effective.” The company declined to comment on its use on the American and Liberian patients.

Dr. Ribner said the Emory medical team learned several things in treating the two Americans, particularly involving replacing fluid and electrolytes in sick patients, and is writing guidelines for practitioners in Africa.

Source: The wall street journal


Special oral health hospitals across India soon

The government plans to set up hospitals exclusively for oral health care at both the national and regional levels, Health Minister Harsh Vardhan said Thursday.

Special oral health hospitals across India soon

“Facilities for dental treatment and oral health are still inadequate in India. In rural areas, they are practically absent,” he said while inaugurating the Centre for Oral Health Promotion at the Centre for Dental Education and Research at the All India Institute of Medical Sciences (AIIMS) here.

The minister said the coming years would see more investment in dental hospitals and colleges at the national and regional levels.

These would have the latest sophisticated equipment and research facilities.
The new centre at AIIMS has been recognised by the World Health Organization as a partner.

“Doctors on their own should act as points of dissemination of information on positive and healthy habits,” Harsh Vardhan said.

“While the government will do its duty of framing policies and schemes and implementing them, it would require the cooperation and involvement of all to make ‘health for all’ a social movement,” he said.

Source: yahoo news


Sleepless teens likelier to get obese

A new study has demonstrated that teenagers who get less than six hours of sleep a night might be at risk of being obese as compared to their peers who sleep more than eight hours.

Sleepless teens likelier to get obese

Researchers at the Mailman School of Public Health at Columbia University and the University of North Carolina Gillings School of Public Health showed that teenagers had a high risk of being obese by age 21 and its was 20 percent higher among 16-year-olds who slept less than six hours.

Shakira F. Suglia, ScD, assistant professor of Epidemiology at the Mailman School, said that lack of sleep in teenage years could stack the deck against one for obesity later in life and if one becomes an obese adult, it was much harder to lose weight and keep it off and the longer one was obese, there was a greater risk for health problems like heart disease, diabetes, and cancer.

Suglia added that the message for parents was to make sure their teenagers got more than eight hours a night and a good night sleep did more than help them stay alert in school and it helped them grew into healthy adults.

The study is published in Journal of Pediatrics

Source: ANI news